Oral factor Xa inhibitors for the long-term management of ACS.

Nature Reviews. Cardiology
James W Wisler, Richard C Becker

Abstract

Despite considerable reductions in cardiovascular events in patients with an acute coronary syndrome (ACS) receiving dual antiplatelet therapy (DAPT), substantial residual risk persists. This unmet need has stimulated the development of anticoagulant drugs that target specific coagulation factors involved in the pathogenesis of thrombosis after atheromatous plaque disruption. Factor Xa is an attractive target for inhibition because of both its integral role in coagulation and its recognized participation in cellular proliferation and inflammation. Several oral, direct factor Xa inhibitors are undergoing investigation and large, phase III clinical trials of two agents, apixaban and rivaroxaban, in patients with an ACS have been completed. On the basis of the known pathobiology of ACS, one might anticipate that drugs in this class of anticoagulant would beneficially reduce ischemic and thrombotic events; however, a strategy of combined anticoagulant therapy and DAPT is likely to increase concomitant bleeding complications. The balance of benefit and risk will ultimately determine uptake in clinical practice. We review the available data on factor Xa inhibitors in the long-term management of patients with an ACS.

References

Feb 6, 1990·Biochemistry·D D Monkovic, P B Tracy
Jun 1, 1996·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·D M MonroeH R Roberts
Jul 1, 1997·Journal of Cellular Physiology·F BonoJ M Herbert
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Jun 19, 2002·Blood·Kathleen E BrummelKenneth G Mann
Sep 27, 2002·The New England Journal of Medicine·Mette HurlenHarald Arnesen
Mar 20, 2003·Journal of the American College of Cardiology·Sonia S Anand, Salim Yusuf
Jan 16, 2004·Oncogene·Henri H VersteegMaikel P Peppelenbosch
Mar 8, 2005·Journal of Thrombosis and Haemostasis : JTH·E PerzbornA Straub
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Oct 4, 2005·Clinical Pharmacology and Therapeutics·Dagmar KubitzaGeorg Wensing
Dec 27, 2005·Current Topics in Medicinal Chemistry·Eddine Saiah, Chris Soares
Feb 16, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Sirak PetrosLothar Engelmann
Mar 16, 2006·The New England Journal of Medicine·UNKNOWN Fifth Organization to Assess Strategies in Acute Ischemic Syndromes InvestigatorsKeith A A Fox
Mar 16, 2006·JAMA : the Journal of the American Medical Association·Salim YusufUNKNOWN OASIS-6 Trial Group
Jun 29, 2006·Blood·Yohei MoritaHiromitsu Nakauchi
Mar 24, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Alexander G G Turpie
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·J Ansell
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
May 9, 2008·Blood·Massimo Franchini, Giuseppe Lippi
Jun 27, 2008·The New England Journal of Medicine·Bengt I ErikssonUNKNOWN RECORD1 Study Group
Jun 27, 2008·The New England Journal of Medicine·Michael R LassenUNKNOWN RECORD3 Investigators
Aug 30, 2008·The New England Journal of Medicine·Bruce Furie, Barbara C Furie
Oct 4, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Nirmala RaghavanDonglu Zhang
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Nov 27, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lifei WangScott J Grossman
Jan 12, 2010·Thrombosis and Haemostasis·Jeffrey I Weitz

❮ Previous
Next ❯

Citations

Jan 12, 2013·International Journal of Clinical Practice·A PerezG J Merli
Oct 8, 2014·Nature Reviews. Cardiology·Francesco Franchi, Dominick J Angiolillo
Mar 1, 2012·Nature Reviews. Cardiology·Katherine P Cabral, Jack Ansell
Feb 24, 2017·Nature Reviews. Cardiology·Francesco FranchiDominick J Angiolillo
May 17, 2018·Critical Pathways in Cardiology·W Brian Gibler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.